Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials

INTRODUCTION: Diabetic ketoacidosis (DKA) is traditionally managed using intravenous regular insulin infusion (RII) in intensive care unit (ICU)/high dependency unit (HDU). Subcutaneous fast-acting insulin analogues (FAIAs) may help to manage DKA outside ICU/HDU. Furthermore, combining subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Beng Leong, Lee, Wei Feng, Lee, Berlin, Chung, Yan Ee Lynette, Loo, Kee Vooi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923333/
https://www.ncbi.nlm.nih.gov/pubmed/36764729
http://dx.doi.org/10.1136/bmjopen-2022-070131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923333/
https://www.ncbi.nlm.nih.gov/pubmed/36764729
http://dx.doi.org/10.1136/bmjopen-2022-070131

Ejemplares similares